Mechanism of antiglycating properties of syringic and chlorogenic acids in in vitro glycation system

Glycation is known to be related with several pathophysiological complications. Several chemical and natural compounds had been tested on different systems to prevent glycation-related complications. Though they show a promising result initially, but often fail to succeed in preclinical trials. In this paper, we try to demonstrate how syringic and chlorogenic acids, two largely consumed natural products bind with BSA to prevent glycation-associated complications. Biochemical (glucose estimation) and biophysical (CD, MALDI, MS/MS) techniques have been used to demonstrate the antiglycating mechanism. We have calculated binding constant 3.07 +/- 0.42 x 10(-4) and 2.67 +/- 0.28 x 10(-4) M-1 for syringic and chlorogenic acids respectively. Further we have successfully purified BSA-phenolic acid conjugates by chromatographic methods. Molecular modeling and mass spectrometric studies suggested that Lys 93,261,232, Arg 194 and Lys 93, Arg 194 are the responsible binding residues for syringic and chlorogenic acids respectively. (C) 2015 Elsevier Ltd. All rights reserved.